APR 30
end channels
New Users Please Click to Register
Renew or Upgrade your Existing  Account
facebook link
HDCN Facebook
off Symposia
Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    ISHD-HDU-2015  :  RRI-2015  :  ISHD-HDU-2014  :  Brigham-2014  :  ISHD-India-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
what new
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)
ishd ISHD Hemodialysis University Chicago (2015)


Harvard Brigham Nephrology Board Review Course (Part 10)   key
Flash or IPAD slide/audio
Boston, MA; August 2014

Electrolytes and Acid-Base Practice for the Boards
Bradley M. Denker MD





Hemodialysis University 2015 (PART 2)   ishd
Flash or IPAD slide/audio
Chicago, IL; October, 2015

Optimizing Dialysate Potassium
David Mendelssohn, MD

Novel Potassium Binding Compounds
Stephen R. Ash, MD

CVC Simulation: Inserting Central Venous Catheters
Jeffrey H. Barsuk, MD



Hypertension, Cardiovascular
Dairy foods and diabetes
Obesity misclassification by BMI
Dx and Tx of Diabetes: ADA 2016 recs
Ablation vs. amiodarone for a. fib
Dairy fat markers and diabetes
Masked and nocturnal HTN in CKD
Diabetic ketoacidosis with canagiflozin
CYP17A1 polymorphisms, steroids, and hypertension
Nocturnal BP fall and prognosis

CKD, Dialysis
Intensive HD and outcome in Australia-NZ
GFR fall increases after sodium phosphate enemas
Bone turnover markers vs. histology
ESA and quality of life in CKD
AST-120 and CKD progression
Intradialytic hypoxemia and outcomes
Older adults with CKD5 managed conservatively - outcomes
Safety concerns with IV iron therapy
LVM changes vs. clinic or ambulatory systolic BP
Roxadustat (prolyl hydroxylase inhibitor) and anemia
GSK 1278863 (prolyl hydroxylase inhibitor) and anemia
Impregnated CVCs and infection risk
High vs. low dialysate sodium - meta
Antimicrobial prophylaxis in PD patients
Decreasing risk of dialysis-related amyloidosis
Iron isomaltoside-100 vs. oral iron sulfate in nondialysis CKD

Clinical Nephrology
Patiromer for diabetic CKD
Hematuria as a marker for occult urinary canceer
Noninfectious renal mixed cryoglobulinemic GN
Daratumumab monotherapy for refractory multiple myeloma
Oral ixaxomib, lenalidomide, and dexamethasone for multiple myeloma

ASN abstracts

key This update's selected ASN 2015 abstracts

BMI and cause of death; Weight reduction improves albuminuria; Meglitinides up risk of hypoglycemia in advanced CKD; Systolic BP and HbA1C vs. outcomes.

CKD, Dialysis
Vascular Access: Delayed thrombectomy bad; AV grafts in the elderly good; Non-transposed brachiobasilic AV fistula results in RCT; Carpal tunnel syndrome and AV fistula.

More bleeding with unfractionated heparin; Anti-platelet factor 4 antibody significance; GI symptoms and hypoalbuminemia; Kt/V and non-urea solutes in HEMO; Removing protein-bound solutes with albumin-binding competitors; Twice-weekly treatment eligibility; Kt/V tracking to detect recirculation; TMAO not a marker of risk in European dialysis patients; Phenylacetylglutamine associated with outcome; Variable recovery time after HD; Recovery time and fluid management; UFR, treatment time, and outcome; Sudden death and dialysate K in DOPPS; Cool dialysate and heart high-energy phosphate levels; 1H NMR metabolome, fungal vs. bacterial peritonitis, and relapsing peritonitis.

Recovery after severe AKI; Geographic distance vs. PD utilization; Thiamine deficiency in nondialysis CKD; Outbreaks of hepatitis C in US dialysis units (CDC); Influenza and outcomes; Pneumonia and outcomes; Two-step tuberculin test; Harm reduction focusing on nephrotoxic medication avoidance; Subcu implantable electronic devices; Drug-eluting vs. bare-metal stents; MI and stroke trends; High UF rates associate with troponin levels; Clinic vs. predialysis BP and CV events in dialysis patients in CRIC; CHA2DS2 scores not useful in dialysis patients; Brain atrophy progression faster in PD.

Clinical Nephrology, Transplantation
Eculizumab in typical and atypical HUS; Markers for acute pyelo in kids; Cast nephropathy vs. ATN in multiple myeloma; Non-collapsing focal and segmental GN in HIV; Serum albumin and venous thromboembolic events in NS; Subclinical pulmonary congestion in NS; Outcomes in transplant recipients switched from MMF to AZT in advance of pregnancy; Detecting bowel cancer in CKD.

 (Kidney Week 2015...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: May 24, 2016 (May24)
May24 CRIC study shows a high urinary sodium excretion in CKD linked to higher CV risk.
May20 SPRINT shows lower than 120 BP systolic target in elderly results in improved outcomes
Apr27 Tetraspanin-7 as an antibody target for type 1 diabete
Apr13 New bacteria called Elizabethkingia affecting Midwest patients.
Mar30 AC6 gene therapy improves cardiac function in patients with heart failure.
Mar30 Oops! Vegetarian diet may have some drawbacks.
Mar17 Updated CKD booklet for professionals released
Mar09 NEJM article re desensitization to HLA-incompatible live donors.
Mar09 Desensitization procedure allows kidney transplants from any (living) donor.
Mar09 ISHD publishes practical manual for implementing home hemodialysis
Mar09 Is the FDA allowing promotion of off-label uses of drugs as free speech?
Feb29 Phage Therapy 2016 World Congress meets this June in Paris.
Feb29 When will be see phage therapy for exit site and access infections?
Feb27 Treatment of BP below 140 systolic in persons with diabetes may be counterproductive.
Feb24 (Off topic). LENR - The Cookbook is in the signal!
Feb22 Some important news re LENR may be released on Wednesday Feb 24.
Feb20 New blood-based tuberculosis test shows promising results.
Feb14 Beetroot juice lowers blood pressure.
Feb14 Second salty taste receptor more fully characterized in humans.
Feb02 CDC warns of increased transmission of hepatitis C in dialysis units.
General Advances Emphasis
featured articles
Seminars in Dialysis
key In quality we trust; but quality of life or quality of care? Drs. Chen, Unruh, and Williams discuss the various definitions of quality, in an issue that is packed with information about efforts to improve outcomes in CKD patients, some written by the CMOs of large dialysis organizations; all in the Mar/Apr issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease Dr. Felsenfeld and colleagues provide a nice overview of mineral bone disorder in this issue which explores many facets of bone disease in CKD; in the Nov/Dec issue of Seminars in Dialysis. (more...)

key Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials
Dr. Kotanko and the FHN Study Group describe the effects of frequent short daily and long nocturnal HD on blood pressure. There were some surprising findings regarding the incidence of intradialytic hypotension; in the July-August issue of Hemodial Int (more...)

Seminars in Dialysis
key Considerations for systemic anticoagulation in ESRD Warfarin, dabigatran, aspirin? Watchful waiting? Other drugs? So many drugs and so little information. Dager and colleagues help guide us through the maze; in the Sept/Oct issue of Seminars in Dialysis. (more...)

key Anticoagulation in chronic hemodialysis: progress toward an optimal approach
In this extremly timely review, Kessler and her colleagues discuss five key issues regarding anticoagulation: standardization, individualization, role of the extracorporeal circuit, options for heparin reduction or avoidance, and optimization of therapy; in the July/August issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Preserving residual renal function in dialysis: what we know
Drs. Patel and Hu review what we can do at the present state of incomplete knowledge; in the May/Jun issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery
Drs. Clark and Bagshaw discuss the potential harms of dialysing patients with suspected AKI too early; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Dietary protein and fiber in end stage renal disease
Tammy Sirich talks about dietary protein, fiber, gut transit time, and gut microbes in uremia, and new ways to modulate blood levels of indoxyl sulfate and p-cresyl sulfate; in the Jan/Feb issue of Seminars in Dialysis. (more...)

free   SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

key   Advances in CKD (Renal Research Institute) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
free   Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
key   The Brigham Renal Board Review Course: Selected Lectures (2014) -- (2013) -- (2012) -- (2011)
key   American Society of Hypertension (2013)   (2012)   (2011)
key   Renal Physicians Association (2012) (2011) (2010) (2009)
key   American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
free   Fistula First (2010)
key   Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
key   National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
key   American Society for Nephrology Renal Week (2009) (2008) (2007)
key   American Society for Nephrology Board Review Course (2008) (2007)
key   American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
key   Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com